In our study, licoricidin breaks the abnormal balance of gastric cancer cells by upregulating Bax and downregulating Bcl-2, thereby leading to the release Cyt-C from the mitochondria into the cytoplasm and to activate Caspase 3. Here, BCL2 is linked to gastric cancer.